Fig. 2: Survival according to MRI findings before and after ASCT.

Progression-free (PFS) and overall survival (OS) analysis in patients with bone-exceeding disease (a and b) as well as patients not achieving CR and with residual diffuse infiltration after ASCT (a and b). PFS (c) and OS (d) for patients with cystic lesion after ASCT